Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 56,314 shares at $76.50 ($4.3M) on 2019-03-14, disclosed to the SEC on 2019-03-14.
Open-market sale of $4.3M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.03 | 2 | $152 | 0.0% |
| 2 | $76.03 | 25 | $2K | 0.0% |
| 3 | $76.03 | 28 | $2K | 0.0% |
| 4 | $76.03 | 44 | $3K | 0.1% |
| 5 | $76.03 | 253 | $19K | 0.4% |
| 6 | $76.03 | 1,648 |
| $125K |
| 2.9% |
| 7 | $76.50 | 891 | $68K | 1.6% |
| 8 | $76.50 | 1,375 | $105K | 2.4% |
| 9 | $76.50 | 61 | $5K | 0.1% |
| 10 | $76.50 | 51,987 | $4.0M | 92.3% |
| Total | $76.48 avg | 56,314 | $4.3M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |